SCHEMBL83583

SCHEMBL83583

[CH2]/C=C/CC[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11266324 1.00
SCHEMBL83584 1.00
SCHEMBL6967600 0.93
SCHEMBL11584052 0.87
SCHEMBL1677325 0.81
SCHEMBL1677328 0.81
SCHEMBL3499180 0.79
SCHEMBL5984389 0.79
SCHEMBL944499 0.79
SCHEMBL5985927 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250200-A1 IMPROVED CATALYSTS FOR INTERMOLECULAR CYCLOADDITION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-08-10 US claimed
US-4338316-A PROSTAGLANDIN F SERIES ANALOGUES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1982-07-06 US claimed
EP-0010360-B1 PROSTANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-06-02 EP claimed
EP-0010360-A1 Prostane derivatives, processes for their preparation and their pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1980-04-30 EP claimed
US-12024595-B2 Polymer composition BASF SE (DE) 2024-07-02 US disclosed
US-20230250200-A1 IMPROVED CATALYSTS FOR INTERMOLECULAR CYCLOADDITION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-08-10 US disclosed
EP-3837301-B1 POLYMER COMPOSITION BASF SE (DE) 2022-06-15 EP disclosed
US-20210347950-A1 POLYMER COMPOSITION BASF SE (DE) 2021-11-11 US disclosed
CN-112912420-A Polymer composition 巴斯夫欧洲公司 2021-06-04 CN disclosed
EP-3536692-B1 PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME MILLENNIUM PHARM INC (US) 2021-04-07 EP disclosed
EP-3452465-B1 SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES GENOSCIENCE PHARMA (FR) 2020-11-04 EP disclosed
US-10577362-B2 Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases GENOSCIENCE PHARMA (FR) 2020-03-03 US disclosed
EP-0577083-A1 7,8-cyclopropataxanes with antitumor action Bristol-Myers Squibb Company (US) 1994-01-05 EP disclosed
EP-0577082-A1 Fluoro taxols with antitumor activity Bristol-Myers Squibb Company (US) 1994-01-05 EP disclosed
US-5272171-A Phosphonooxy and carbonate derivatives of taxol BRISTOL-MYERS SQUIBB COMPANY (US) 1993-12-21 US disclosed
US-5254580-A 7,8-cyclopropataxanes BRISTOL-MYERS SQUIBB COMPANY (US) 1993-10-19 US disclosed
EP-0558959-A1 Phosphonooxy and carbonate derivatives of taxol Bristol-Myers Squibb Company (US) 1993-09-08 EP disclosed
US-4338316-A PROSTAGLANDIN F SERIES ANALOGUES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1982-07-06 US disclosed
EP-0010360-B1 PROSTANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-06-02 EP disclosed
EP-0010360-A1 Prostane derivatives, processes for their preparation and their pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1980-04-30 EP disclosed